Discovering that your dog has epilepsy can be frightening. That the cause of the recurring seizures cannot be identified—known as idiopathic epilepsy—only makes matters worse. But there is some good news. A large, nationwide veterinary clinical trial for the purpose of evaluating a new medication for the treating idiopathic epilepsy is underway. The trial not only means a boost for research, it may be a boost for recession-strapped guardians.
Despite estimates that idiopathic epilepsy may affect up to 5.7 percent of the dog population in the United States, very little is known about this disease. This study, the largest-known trial of its kind, should provide the foundation for new insights and treatments. Regulated by the Food and Drug Administration (FDA), the veterinary clinical trial is being conducted in multiple cities with hundreds of dogs.
Will your dog qualify? Participating dogs must be at least 4 months old, have not been previously treated with anti-seizure medication, weigh at least 11 pounds, and have no previous history of seizure clusters or status epilepticus. In addition, dogs cannot be pregnant or suspected to be pregnant and must be evaluated an investigator within seven days of the most recent seizure.
Here’s the bonus: Dogs that meet the initial qualifications for the study receive free medical evaluations, as well as in-depth diagnostic tests, which may include a CAT scan or MRI. If enrolled in the study, dogs also receive free medication (no placebo) and monthly exams. In addition to free study specific care, owners of enrolled dogs are also eligible to have funds credited to their accounts at their referring family veterinarian.
For more information, talk to your veterinarian, review these frequently asked questions, or call 1-888-598-7125, ext. 208.